RxSight, Inc. (RXST)
6.54
-0.49
(-6.97%)
USD |
NASDAQ |
Sep 03, 16:00
6.54
0.00 (0.00%)
After-Hours: 20:00
RxSight Research and Development Expense (Annual) : 38.55M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 38.55M |
| December 31, 2024 | 34.37M |
| December 31, 2023 | 29.05M |
| December 31, 2022 | 25.98M |
| Date | Value |
|---|---|
| December 31, 2021 | 24.50M |
| December 31, 2020 | 21.93M |
| December 31, 2019 | 29.57M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Precision Optics Corp., Inc. | 1.158M |
| Alcon AG | 990.00M |
| The Cooper Cos., Inc. | 172.20M |
| UFP Technologies, Inc. | 8.60M |
| TransMedics Group, Inc. | 69.06M |